Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Biomed Mater Res A. 2020 Aug 25;109(6):893–902. doi: 10.1002/jbm.a.37080

FIGURE 3.

FIGURE 3

MUC4β antigen epitope availability (represented as an OD@405 nm) upon recognition by distinct anti-MUC4β mAbs. Indirect ELISA was used to assess the reactivity of each mAb against MUC4β released from the nanoparticles. No significant differences relative to the control MUC4β (at the same MUC4β coating concentration) were observed with mAbs 6E8 and E9. Reactivity of anti-MUC4α mAb 8G7 was not significantly different from the no-antigen-coating control. Error bars represent SEM. No significance was observed in comparison to the corresponding control (using p < 0.05). mAbs, monoclonal antibodies